S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

INDP Indaptus Therapeutics Inc

1.49

-0.06 (-3.87%)

19 Oct 2024 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics Inc News

Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
Tuesday 15 October 2024 (5 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 11 October 2024 (1 week ago) • Edgar (US Regulatory)

Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer Immunotherapy
Thursday 10 October 2024 (1 week ago) • GlobeNewswire Inc.

Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Tuesday 8 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Form D/A - Notice of Exempt Offering of Securities: [Amend]
Saturday 5 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Friday 13 September 2024 (1 month ago) • Edgar (US Regulatory)

Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses
Thursday 5 September 2024 (1 month ago) • GlobeNewswire Inc.

Indaptus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Tuesday 3 September 2024 (2 months ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 12 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 12 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 12 August 2024 (2 months ago) • Edgar (US Regulatory)

Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Monday 12 August 2024 (2 months ago) • GlobeNewswire Inc.

More Indaptus Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions